RxDoctor Payments Data

Jain Joseph, MD

Plastic and Reconstructive Surgery · Berkeley Heights, NJNPI 1265745111

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 45.4% of the total. 2025 is the largest year on record at $643, 5.8 times the $110 reported in 2020. That places this record below the midpoint for plastic and reconstructive surgery clinicians in NJ, where the typical reported total is $1,513.

$1,179in general payments, 2019–2025

Across 40 payments — averaging $29.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$535
  • Mentor Worldwide LLC$268
  • Musculoskeletal Transplant Foundation Inc.$135
  • Polarityte, Inc.$110
  • Revance Therapeutics, Inc.$48
  • Baxter Healthcare$47
  • plus $34 from 1 others

What the payments were for

  • Food & beverage$1,179100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,179 in reported general payments places this provider in the 40th percentile of 93 plastic and reconstructive surgery providers in New Jersey.

See all plastic and reconstructive surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$100,321
Medicare patients
123
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin42$298
Doxycycline Hyclate11$91

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Berkeley Heights

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →